These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20842433)

  • 1. Update on mitochondrial fatty acid oxidation disorders.
    Spiekerkoetter U; Mayatepek E
    J Inherit Metab Dis; 2010 Oct; 33(5):467-8. PubMed ID: 20842433
    [No Abstract]   [Full Text] [Related]  

  • 2. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.
    Wanders RJ; Ruiter JP; IJLst L; Waterham HR; Houten SM
    J Inherit Metab Dis; 2010 Oct; 33(5):479-94. PubMed ID: 20490924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of fatty acid oxidation disorders.
    Bennett MJ
    J Inherit Metab Dis; 2010 Oct; 33(5):533-7. PubMed ID: 20824345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation.
    Houten SM; Wanders RJ
    J Inherit Metab Dis; 2010 Oct; 33(5):469-77. PubMed ID: 20195903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current issues regarding treatment of mitochondrial fatty acid oxidation disorders.
    Spiekerkoetter U; Bastin J; Gillingham M; Morris A; Wijburg F; Wilcken B
    J Inherit Metab Dis; 2010 Oct; 33(5):555-61. PubMed ID: 20830526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid oxidation disorders: outcome and long-term prognosis.
    Wilcken B
    J Inherit Metab Dis; 2010 Oct; 33(5):501-6. PubMed ID: 20049534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.
    Lund AM; Skovby F; Vestergaard H; Christensen M; Christensen E
    J Inherit Metab Dis; 2010 Oct; 33(5):495-500. PubMed ID: 20066495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease mechanisms and protein structures in fatty acid oxidation defects.
    Gregersen N; Olsen RK
    J Inherit Metab Dis; 2010 Oct; 33(5):547-53. PubMed ID: 20151199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency.
    van Maldegem BT; Wanders RJ; Wijburg FA
    J Inherit Metab Dis; 2010 Oct; 33(5):507-11. PubMed ID: 20429031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.
    Spiekerkoetter U
    J Inherit Metab Dis; 2010 Oct; 33(5):527-32. PubMed ID: 20449660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.
    Spiekerkoetter U; Wood PA
    J Inherit Metab Dis; 2010 Oct; 33(5):539-46. PubMed ID: 20532823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting.
    Lindner M; Hoffmann GF; Matern D
    J Inherit Metab Dis; 2010 Oct; 33(5):521-6. PubMed ID: 20373143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enzymes of mitochondrial fatty acid oxidation.
    Bennett MJ
    Clin Chim Acta; 1994 May; 226(2):211-24. PubMed ID: 7923814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation.
    Rinaldo P; Studinski AL; Matern D
    Prenat Diagn; 2001 Jan; 21(1):52-4. PubMed ID: 11180241
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population.
    Schatz UA; Ensenauer R
    J Inherit Metab Dis; 2010 Oct; 33(5):513-20. PubMed ID: 20532824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid oxidation disorders: maternal health and neonatal outcomes.
    Rector RS; Ibdah JA
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):122-8. PubMed ID: 19926542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic mitochondrial fatty acid oxidation disorders].
    Matsubara Y
    Ryoikibetsu Shokogun Shirizu; 1995; (8):312-6. PubMed ID: 8581639
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mitochondrial beta-oxidation defects: overview].
    Yamaguchi S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):60-4. PubMed ID: 11596451
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders].
    Peña Quintana L; Sanjurjo Crespo P
    An Esp Pediatr; 2001 Dec; 55(6):524-34. PubMed ID: 11730586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.